These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein. Wysolmerski JJ; Broadus AE Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376 [TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia of cancer: an update. Goni MH; Tolis G Anticancer Res; 1993; 13(4):1155-60. PubMed ID: 8352538 [TBL] [Abstract][Full Text] [Related]
7. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein. Insogna KL Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773 [TBL] [Abstract][Full Text] [Related]
8. [Malignant hypercalcemia with and without bone metastasis]. Millán Núñez-Cortés J; de Moneo González A Rev Clin Esp; 1996 Jun; 196(6):388-91. PubMed ID: 8767075 [No Abstract] [Full Text] [Related]
9. [Pathogenesis of hypercalcemia associated with malignant tumors]. François D; Body JJ; Nijs-De Wolf N; Fuss M; Gillet C; Corvilain J Rev Med Brux; 1987; 8(6-7):359-62. PubMed ID: 2823362 [No Abstract] [Full Text] [Related]
10. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases. de Vernejoul MC Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953 [No Abstract] [Full Text] [Related]
11. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors. Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357 [TBL] [Abstract][Full Text] [Related]
12. Synthetic peptides as tools for investigating the pathogenicity of disease: humoral hypercalcemia of malignancy. McKee RL; Caulfield MP Pept Res; 1989; 2(2):161-6. PubMed ID: 2520752 [No Abstract] [Full Text] [Related]
13. [Differential diagnosis of hypercalcemia]. Elomaa I Duodecim; 1990; 106(4):375-9. PubMed ID: 1670103 [No Abstract] [Full Text] [Related]
14. Is there a role for parathyroid hormone in humoral hypercalcemia of malignancy? Stewart AF Miner Electrolyte Metab; 1982; 8(3-4):215-26. PubMed ID: 6300632 [No Abstract] [Full Text] [Related]
15. Parathyroid hormone-related peptide and hypercalcemia of malignancy. Goltzman D; Henderson JE Cancer Treat Res; 1997; 89():193-215. PubMed ID: 9204194 [No Abstract] [Full Text] [Related]
16. Etiology and current management of cancer-related hypercalcemia. Warrell RP Oncology (Williston Park); 1992 Oct; 6(10):37-43; discussion 43, 47-50. PubMed ID: 1390013 [TBL] [Abstract][Full Text] [Related]
17. Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. Broadus AE; Mangin M; Ikeda K; Insogna KL; Weir EC; Burtis WJ; Stewart AF N Engl J Med; 1988 Sep; 319(9):556-63. PubMed ID: 3043221 [No Abstract] [Full Text] [Related]
18. Hypercalcemia and cancer: an update. Murray TM; Josse RG; Heersche JN Can Med Assoc J; 1978 Oct; 119(8):915-20. PubMed ID: 367555 [TBL] [Abstract][Full Text] [Related]
19. Humoral hypercalcemia of malignancy. Martin TJ Bone Miner; 1988 Apr; 4(1):83-9. PubMed ID: 3056542 [No Abstract] [Full Text] [Related]
20. Hypercalcemia of malignancy--new insights into an old syndrome. Esbrit P Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]